{"id":"placebo-for-micronized-progesterone","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo response (non-specific symptom improvement)"}]},"_chembl":{"chemblId":"CHEMBL103","moleculeType":"Small molecule","molecularWeight":"314.47"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo for micronized progesterone","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:40:46.699447+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:40:58.253174+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo for micronized progesterone","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:40:59.218909+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Progesterone receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:41:00.539248+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL103/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:41:00.446804+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert formulations used as control comparators in clinical trials to distinguish true drug effects from placebo response. In this case, it serves as a control for micronized progesterone studies, allowing researchers to measure the actual therapeutic benefit of the active hormone independent of psychological or expectation-based effects.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:54.403Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:41:02.218072+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Control comparator in clinical trials for micronized progesterone formulations"}]},"trialDetails":[{"nctId":"NCT02518594","phase":"PHASE3","title":"A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2015-11-13","conditions":"Short Cervical Length","enrollment":1311},{"nctId":"NCT02633878","phase":"PHASE3","title":"Chinese Herbal Medicine (New \"Shoutai Wan\") and/or Oral Progesterone Intervention Trial for Threatened Miscarriage","status":"COMPLETED","sponsor":"Heilongjiang University of Chinese Medicine","startDate":"2017-10-20","conditions":"Threatened Miscarriage","enrollment":1656},{"nctId":"NCT04112368","phase":"PHASE4","title":"Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-09-15","conditions":"Suicidal Ideation","enrollment":124},{"nctId":"NCT03068910","phase":"EARLY_PHASE1","title":"Hyperandrogenemia and Altered Day-night LH Pulse Patterns","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2016-07-21","conditions":"Hyperandrogenism, Polycystic Ovary Syndrome, Puberty","enrollment":32},{"nctId":"NCT06856174","phase":"PHASE4","title":"Menopausal HT for Women Living With HIV (HoT)","status":"NOT_YET_RECRUITING","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2026-01-19","conditions":"HIV Infection, Menopause","enrollment":105},{"nctId":"NCT03740204","phase":"PHASE2","title":"The Role of Estrogen in the Neurobiology of Eating Disorders","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-06-13","conditions":"Eating Disorders, Hypoestrogenemia","enrollment":120},{"nctId":"NCT05282277","phase":"PHASE4","title":"Examining the Effects of Estradiol on Neural and Molecular Response to Reward","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-20","conditions":"Depression, Psychosis, Anhedonia","enrollment":103},{"nctId":"NCT06091436","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-03-24","conditions":"Infertility","enrollment":176},{"nctId":"NCT00703014","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-13","conditions":"Pregnancy, Neonates","enrollment":541},{"nctId":"NCT00702273","phase":"","title":"Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-19","conditions":"In Vitro Fertilization","enrollment":344},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT02460302","phase":"PHASE2","title":"Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy","status":"WITHDRAWN","sponsor":"Mount Sinai Hospital, Canada","startDate":"2016-12","conditions":"Atrophic Vaginitis, Menopause, Vulvovaginal Atrophy","enrollment":""},{"nctId":"NCT04597099","phase":"EARLY_PHASE1","title":"Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2022-10-26","conditions":"PCOS, Polycystic Ovary Syndrome","enrollment":10},{"nctId":"NCT04865029","phase":"PHASE2","title":"Estradiol and Progesterone in Hospitalized COVID-19 Patients","status":"TERMINATED","sponsor":"Tulane University","startDate":"2021-07-22","conditions":"Covid19","enrollment":10},{"nctId":"NCT02430233","phase":"PHASE4","title":"Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2018-12-19","conditions":"Preterm Labor","enrollment":129},{"nctId":"NCT03498313","phase":"PHASE4","title":"Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2018-07-27","conditions":"Suicidal Ideation","enrollment":60},{"nctId":"NCT04225221","phase":"PHASE2","title":"Neurobiology of Bulimia Nervosa","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-02-24","conditions":"Bulimia Nervosa","enrollment":10},{"nctId":"NCT01301183","phase":"PHASE3","title":"Effects of Anorexia Nervosa on Peak Bone Mass","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2011-02","conditions":"Anorexia Nervosa","enrollment":75},{"nctId":"NCT01441635","phase":"PHASE2","title":"Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2011-09-08","conditions":"Heavy Uterine Bleeding, Uterine Fibroids","enrollment":271},{"nctId":"NCT00946192","phase":"PHASE3","title":"Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-05","conditions":"Exercise-related Amenorrhea","enrollment":121},{"nctId":"NCT03003949","phase":"PHASE4","title":"The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-01-24","conditions":"Perimenopausal Disorder, Stress, Emotional","enrollment":82},{"nctId":"NCT03677336","phase":"PHASE4","title":"Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-05-01","conditions":"Infertility, Female, Infertility, Genital Diseases, Male","enrollment":30},{"nctId":"NCT02779582","phase":"PHASE3","title":"Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2015-06","conditions":"Perimenopause, Menstrual Cramps","enrollment":59},{"nctId":"NCT03774745","phase":"PHASE1, PHASE2","title":"Blocking Mifepristone Action With Progesterone","status":"TERMINATED","sponsor":"University of California, Davis","startDate":"2019-02-11","conditions":"Pregnancy, Unwanted","enrollment":12},{"nctId":"NCT01464697","phase":"PHASE3","title":"Progesterone for Perimenopausal Night Sweats","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2011-10","conditions":"Hot Flushes, Night Sweats","enrollment":249},{"nctId":"NCT01744574","phase":"NA","title":"Sex Differences, Hormones & Smoking Cessation","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2012-12","conditions":"Tobacco Cessation","enrollment":216},{"nctId":"NCT01840228","phase":"NA","title":"Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2013-05","conditions":"Premature Birth, Obstetric Labor, Premature","enrollment":38},{"nctId":"NCT01180296","phase":"PHASE3","title":"Oral Progesterone for Prevention of Preterm Birth","status":"COMPLETED","sponsor":"Fetal Medicine Foundation","startDate":"2006-11","conditions":"Preterm Birth","enrollment":36},{"nctId":"NCT03720847","phase":"PHASE4","title":"Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2016-12-31","conditions":"Suicidal Ideation","enrollment":30},{"nctId":"NCT02272647","phase":"PHASE1","title":"Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-12","conditions":"Healthy","enrollment":47},{"nctId":"NCT01972464","phase":"PHASE2","title":"Progesterone for Smoking Relapse Prevention Following Delivery","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-11","conditions":"Tobacco Use Disorder","enrollment":41},{"nctId":"NCT01850030","phase":"PHASE3","title":"A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization","status":"COMPLETED","sponsor":"Abbott","startDate":"2013-08","conditions":"Female Infertility","enrollment":1070},{"nctId":"NCT01762943","phase":"NA","title":"Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2013-08","conditions":"Postpartum Depression","enrollment":36},{"nctId":"NCT01308814","phase":"PHASE2, PHASE3","title":"Perimenopausal Estrogen Replacement Therapy Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2010-10","conditions":"Perimenopause, Menopause, Depression","enrollment":172},{"nctId":"NCT02524561","phase":"NA","title":"KEEPS Mammographic Density And Breast Health Ancillary Study","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2005-09","conditions":"Mammographic Density, Abnormal Mammogram","enrollment":517},{"nctId":"NCT01798394","phase":"NA","title":"Progesterone & Postpartum Relapse to Smoking","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-06","conditions":"Tobacco Use Cessation, Tobacco Use Disorder","enrollment":46},{"nctId":"NCT01523483","phase":"NA","title":"Vaginal Progesterone for Prevention of Preterm Birth After an Episode of Preterm Labor","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2012-03","conditions":"Preterm Birth","enrollment":30},{"nctId":"NCT00196391","phase":"PHASE2","title":"A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea","status":"COMPLETED","sponsor":"Duramed Research","startDate":"2005-09","conditions":"Amenorrhea","enrollment":180},{"nctId":"NCT00632099","phase":"PHASE2, PHASE3","title":"Progesterone Treatment for Cocaine-dependent Women: A Pilot Study","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-02","conditions":"Cocaine Dependence","enrollment":21},{"nctId":"NCT00154180","phase":"PHASE4","title":"Kronos Early Estrogen Prevention Study (KEEPS)","status":"UNKNOWN","sponsor":"Kronos Longevity Research Institute","startDate":"2005-09","conditions":"Menopause, Arteriosclerosis","enrollment":728}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL103"},"_approvalHistory":[],"publicationCount":124,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo for micronized progesterone","genericName":"Placebo for micronized progesterone","companyName":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","companyId":"advancing-clinical-therapeutics-globally-for-hiv-aids-and-other-infections","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control comparator in clinical trials for micronized progesterone formulations.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T05:41:02.218072+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}